3.	Loss Per Share

As of September 30, 2013 and 2012, the Company only had one issued and outstanding class of stock – common stock. As a result, the basic loss per share for the three and nine months ended September 30, 2013 and 2012 is computed by dividing net loss by the weighted average number of common shares outstanding for the period.

The following table provides a reconciliation of the denominators of the Company’s reported basic and diluted earnings per share computation for the three and nine months ended September 30, 2013 and 2012, respectively:


	For the three months ended September 30,				For the nine months ended September 30,
	2013		2012		2013		2012
Weighted number of common shares – basic		12,007,667		11,904,469		11,985,629		11,888,660
Common stock equivalents		—		—		—		—

Weighted number of common shares – diluted		12,007,667		11,904,469		11,985,629		11,888,660

The computed loss per share does not assume conversion, exercise, or contingent exercise of securities that would have an antidilutive effect on loss per share. As the Company was in a net loss position for the three and nine month periods ended September 30, 2013 and 2012, all common stock equivalents in these periods were antidilutive.

The following represents issuable weighted average share information for the respective periods:


	For the three months ended September 30,				For the nine months ended September 30,
	2013		2012		2013		2012
Common stock options		25,313		18,785		51,992		21,281
Common stock warrants		311		8,305		828		26,171
Unvested restricted stock		34,929		14,945		38,431		9,065

Total common stock equivalents		60,553		42,035		91,251		56,517

In addition, common stock options, unvested restricted stock and common stock warrants of 480,914, 30,000 and 45,045, respectively, were excluded from the calculation of net loss per share, as inclusion of such shares would be antidilutive due to exercise prices or value of proceed shares exceeding the average market price of the Company’s common stock during the three months ended September 30, 2013, and common stock options, unvested restricted stock and common stock warrants of 469,463, 25,000 and 45,045, respectively, were excluded from the calculation of net loss per share, as inclusion of such shares would be antidilutive due to exercise prices or value of proceed shares exceeding the average market price of the Company’s common stock during the nine months ended September 30, 2013.

Common stock options of 711,989 and 676,051, respectively, were excluded from the calculation of net loss per share, as inclusion of such shares would be antidilutive due to exercise prices or value of proceed shares exceeding the average market price of the Company’s common stock during the three and nine months ended September 30, 2012, respectively.